Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate.

Modern rheumatology / the Japan Rheumatism Association

Volumn 20, Issue 4, 2010, Pages 343-352

  Nakashima, Yasuharu ^a   Kondo, Masakazu ^b   Harada, Hiroshi ^b   Horiuchi, Takahiko ^b   Ishinishi, Takashi ^b   Jojima, Hiroshi ^b   Kuroda, Koji ^b   Miyahara, Hisaaki ^b   Nagamine, Ryuji ^b   Nakashima, Hitoshi ^b   Otsuka, Takeshi ^b   Saikawa, Isao ^b   Shono, Eisuke ^b   Suematsu, Eiichi ^b   Tsuru, Tomomi ^b   Wada, Ken ^b   Iwamoto, Yukihide ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; POSTMARKETING SURVEILLANCE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78349285989     PISSN: None     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0290-x     Document Type: Article

References (0)